Lingling Zu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- Physiology top 10%
Papers in
-
- Lung Cancer Treatments and Mutations 7
- Lung Cancer Diagnosis and Treatment 6
- Ferroptosis and cancer prognosis 5
-
- RNA modifications and cancer 4
- Co-authors
- Yang Li (7 shared papers)Jiacong You (5 shared papers)Qinghua Zhou (10 shared papers)Qinghua Zhou (6 shared papers)Xuebing Li (8 shared papers)Song Xu (20 shared papers)Jun Du (1 shared paper)Qing Yang (1 shared paper)
- Journals
- Cancer Medicine (4 papers)Frontiers in Oncology (3 papers)Cancers (3 papers)Translational Lung Cancer Research (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesBrazil
In The Last Decade
Lingling Zu
54 papers receiving 737 citations
Peers
Comparison fields: 5 of 77
- Cancer Research 296
- Physiology 40
- Oncology 145
- Molecular Biology 387
- Geriatrics and Gerontology 12
Countries citing papers authored by Lingling Zu
This map shows the geographic impact of Lingling Zu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingling Zu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingling Zu more than expected).
Fields of papers citing papers by Lingling Zu
This network shows the impact of papers produced by Lingling Zu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingling Zu. The network helps show where Lingling Zu may publish in the future.
Co-authors
The 25 scholars most cited alongside Lingling Zu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 56 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 94 | |
| 2 | 2014 | 60 | |
| 3 | 2013 | 56 | |
| 4 | 2015 | 46 | |
| 5 | 2017 | 35 | |
| 6 | MiR-449a suppresses cell invasion by inhibiting MAP2K1 in non-small cell lung cancer. | 2015 | 35 |
| 7 | 2016 | 33 | |
| 8 | 2020 | 29 | |
| 9 | 2014 | 28 | |
| 10 | 2021 | 20 | |
| 11 | 2023 | 20 | |
| 12 | 2022 | 19 | |
| 13 | 2021 | 17 | |
| 14 | 2021 | 16 | |
| 15 | 2022 | 16 | |
| 16 | 2023 | 16 | |
| 17 | 2014 | 15 | |
| 18 | 2021 | 15 | |
| 19 | 2023 | 14 | |
| 20 | 2016 | 14 |
About Lingling Zu
Lingling Zu is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Surgery, having authored 56 papers that have together received 746 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (7 papers), Lung Cancer Diagnosis and Treatment (6 papers), Cancer Genomics and Diagnostics (5 papers), Ferroptosis and cancer prognosis (5 papers), Cancer Immunotherapy and Biomarkers (5 papers), Cancer-related molecular mechanisms research (5 papers), RNA modifications and cancer (4 papers) and Lung Cancer Research Studies (3 papers). The work is most often cited by research in Cancer Research (296 citations), Physiology (40 citations), Oncology (145 citations), Molecular Biology (387 citations) and Geriatrics and Gerontology (12 citations). Lingling Zu has collaborated with scholars based in China, United States and Brazil. Frequent co-authors include Yang Li, Jiacong You, Qinghua Zhou, Qinghua Zhou, Xuebing Li, Song Xu, Jun Du, Qing Yang, Rui Chang and Ning Zhou. Their work appears in journals such as Cancer Medicine, Frontiers in Oncology, Cancers, Translational Lung Cancer Research and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.